# Polatuzumab Vedotin (Genetical Recombination) for I.V. Infusion 30mg (ポライビー点滴静注用３０ｍｇ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 4291455D1022). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 4291455D1022
- **Product name (Japanese):** ポライビー点滴静注用３０ｍｇ
- **English title:** Polatuzumab Vedotin (Genetical Recombination) for I.V. Infusion 30mg
- **Active ingredient:** ポラツズマブ ベドチン（遺伝子組換え）
- **Active ingredient (INN):** Polatuzumab Vedotin (Genetical Recombination)
- **Strength / unit:** ３０ｍｇ１瓶
- **Route:** Injection (注射薬)
- **Therapeutic category:** 42 Antineoplastics (腫瘍用薬) › 429 Other antineoplastics (その他の腫瘍用薬)
- **Manufacturer:** Chugai Pharmaceutical (中外製薬)
- **NHI price (reference only):** JPY 254001 per ３０ｍｇ１瓶
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/4291455D1022
- **JSON:** https://www.nifujipharma.com/api/drugs/4291455D1022

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Polatuzumab%20Vedotin%20(Genetical%20Recombination)%20for%20I.V.%20Infusion%2030mg%20(%E3%83%9D%E3%83%A9%E3%82%A4%E3%83%93%E3%83%BC%E7%82%B9%E6%BB%B4%E9%9D%99%E6%B3%A8%E7%94%A8%EF%BC%93%EF%BC%90%EF%BD%8D%EF%BD%87)%20%2F%20YJ%204291455D1022#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.

## Other listed products with Polatuzumab Vedotin (Genetical Recombination)

- [Polatuzumab Vedotin (Genetical Recombination) for I.V. Infusion 140mg (ポライビー点滴静注用１４０ｍｇ)](https://www.nifujipharma.com/drugs/4291455D2029) — １４０ｍｇ１瓶, Chugai Pharmaceutical